NewsBenzingaRaymond James对Palisade Bio启动覆盖,给予“跑赢大盘”评级,并宣布目标价为6美元 Raymond James对Palisade Bio启动覆盖,给予“跑赢大盘”评级,并宣布目标价为6美元 Benzinga 2026.10.09 11:11 (GMT+0) Open on Benzinga Other news Susquehanna Maintains Positive on United Airlines Holdings, Lowers Price Target to $130 Susquehanna Maintains Positive on Meta Platforms, Raises Price Target to $850 Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients Susquehanna Maintains Neutral on IBM, Raises Price Target to $256 Susquehanna Maintains Neutral on Genpact, Raises Price Target to $40 Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $905
Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients